Abbas Heba Salah, Kotakonda Muddukrishnaiah
Microbiology Department, National Organization for Drug Control and Research (NODCAR), Egyptian Drug Authority, Giza, Egypt.
Department of Pharmaceutical Technology, Bharathidasan Institute of Technology, Anna University, Tiruchirappalli-620024.Tamilnadu, India.
Adv Pharm Bull. 2022 Mar;12(2):319-328. doi: 10.34172/apb.2022.030. Epub 2021 Mar 27.
Today the crisis of coronavirus disease 2019 (COVID-19) pandemic represents a threatworldwide because it is a leading cause of human morbidity and mortality. Besides, it possessesa destroying impact on countries' economies. Therefore, there is an urgent need for hardresearch work and global collaboration to find a potential therapy. In this review, structuralgenomic variations in COVID-19 and further therapeutic options of Coronaviridae family orCOVID-19 are expressed. Lectins are natural proteins, which can exist in algae, higher plants,banana, actinomycetes, fungi, and archaea, and they have antiviral properties. Griffithsin lectin,isolated from red algae, has noteworthy efficacy against lethal SARS-CoV infection, humancoronaviruses, and other animal coronaviruses. Furthermore, all mannose-specific plant lectinshave anti-coronaviruses properties except for garlic lectins. However, lectins from mushroomscan act as immunomodulators by activating T-lymphocyte or stimulating dendrites or cytokines.The lectin may hinder glucans on viral spike protein and prevent entry and the virus's release.Lectin's anti-coronavirus activities include a glimmer of hope to tackle the global COVID-19crisis and inspire more scientific work on carbohydrate-binding agents against SARS-CoV-2.
如今,2019冠状病毒病(COVID-19)大流行危机在全球构成威胁,因为它是人类发病和死亡的主要原因。此外,它对各国经济具有破坏性影响。因此,迫切需要开展深入的研究工作和全球合作以找到潜在的治疗方法。在这篇综述中,阐述了COVID-19的结构基因组变异以及冠状病毒科或COVID-19的进一步治疗选择。凝集素是天然蛋白质,存在于藻类、高等植物、香蕉、放线菌、真菌和古生菌中,具有抗病毒特性。从红藻中分离出的格里菲斯凝集素对致死性严重急性呼吸综合征冠状病毒(SARS-CoV)感染、人类冠状病毒和其他动物冠状病毒具有显著疗效。此外,除大蒜凝集素外,所有甘露糖特异性植物凝集素都具有抗冠状病毒特性。然而,蘑菇中的凝集素可通过激活T淋巴细胞、刺激树突或细胞因子来充当免疫调节剂。凝集素可能会阻碍病毒刺突蛋白上的葡聚糖,阻止病毒进入和释放。凝集素的抗冠状病毒活性为应对全球COVID-19危机带来了一线希望,并激发了更多针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的碳水化合物结合剂的科学研究工作。